GlassScriptPhysician profile
Deborah Summers
NPI 1962620906
$1,633.64
in general payments reported to CMS, 2019-2025
9 companies · $235 in 2025
The $235 reported for 2025 was more than what a typical Medical-Surgical (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $167).
See the full distribution for Medical-Surgical (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $437 · 2022: $164 · 2023: $141 · 2024: $656 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,032.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,032.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $567.76 | 2021-2024 | |
| Ucb, INC. | $386.91 | 2022-2024 | Briviact, Nayzilam |
| Biogen, INC. | $187.46 | 2021 | |
| Integra Lifesciences Corporation | $180.69 | 2021-2025 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Hakim |
| Emd Serono, INC. | $144.21 | 2025 | Mavenclad |
| Neurelis, INC. | $59.37 | 2024 | Valtoco |
| Jazz Pharmaceuticals INC. | $53.57 | 2023 | |
| Genentech USA, INC. | $33.38 | 2021-2022 | |
| Genentech, INC. | $20.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Summers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.